1,3-dibromo-5,5-dimethylhydantoin; Exemption From the Requirement of a Tolerance, 57367-57370 [2017-25842]
Download as PDF
57367
Federal Register / Vol. 82, No. 232 / Tuesday, December 5, 2017 / Rules and Regulations
EPA-APPROVED NEW YORK STATE REGULATIONS AND LAWS—Continued
State
effective
date
State citation
Title/subject
Title 6, Part 245 .....................................
Transport Rule SO2 Group 1 Trading
Program.
*
*
*
*
*
*
*
*
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2011–1033; FRL–9968–30]
1,3-dibromo-5,5-dimethylhydantoin;
Exemption From the Requirement of a
Tolerance
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes an
exemption from the requirement of a
tolerance for residues of 1,3-dibromo5,5-dimethylhydantoin in or on food
when used in antimicrobial pesticide
formulations applied to food contact
surfaces in public eating places, dairy
processing equipment, and/or food
processing equipment and utensils. In
addition, this regulation establishes an
exemption from the requirement of a
tolerance for residues of 1,3-dibromo5,5-dimethylhydantoin when used as an
antimicrobial pesticide treatment
solution. Albemarle Corporation
submitted a petition to EPA under the
Federal Food, Drug, and Cosmetic Act
(FFDCA), requesting exemptions from
the requirement of a tolerance for
residues of 1,3-dibromo-5,5dimethylhydantoin in end-use products
applied to food contact surfaces and
used for washing raw agricultural
commodities. This regulation eliminates
the need to establish a maximum
permissible level of residues of 1,3dibromo-5,5-dimethylhydantoin
resulting from uses consistent with the
terms of these exemptions.
DATES: This regulation is effective
December 5, 2017. Objections and
requests for hearings must be received
on or before February 5, 2018, and must
be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
sradovich on DSK3GMQ082PROD with RULES
SUMMARY:
VerDate Sep<11>2014
17:53 Dec 04, 2017
12/17/15
*
Jkt 244001
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2011–1033, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Steven H. Weiss, Antimicrobials
Division (7510P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460–0001; main
telephone number: (703) 308–6411;
email address: ADFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111),
e.g., agricultural workers; greenhouse,
nursery, and floriculture workers;
farmers.
• Animal production (NAICS code
112), e.g., cattle ranchers and farmers,
dairy cattle farmers, livestock farmers.
• Food manufacturing (NAICS code
311), e.g., agricultural workers; farmers;
greenhouse, nursery, and floriculture
workers; ranchers; pesticide applicators.
PO 00000
Frm 00037
Fmt 4700
12/5/17
*
ADDRESSES:
[FR Doc. 2017–26079 Filed 12–4–17; 8:45 am]
EPA approval
date
Sfmt 4700
*
Comments
• EPA approval finalized
at [insert Federal Register citation].
• Conditional Approval.
*
• Pesticide manufacturing (NAICS
code 32532), e.g., agricultural workers;
commercial applicators; farmers;
greenhouse, nursery, and floriculture
workers; residential users.
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of 40 CFR part 180
through the Government Printing
Office’s e-CFR site at https://
www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&
tpl=/ecfrbrowse/Title40/40tab_02.tpl.
To access the OSCPP test guidelines
referenced in this document
electronically, please go to https://
www.epa.gov/ocspp and select ‘‘Test
Methods and Guidelines.’’
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2011–1033 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before February 5, 2018. Addresses for
mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2011–1033, by one of the following
methods:
E:\FR\FM\05DER1.SGM
05DER1
57368
Federal Register / Vol. 82, No. 232 / Tuesday, December 5, 2017 / Rules and Regulations
sradovich on DSK3GMQ082PROD with RULES
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on commenting
or visiting the docket, along with more
information about dockets generally, is
available at https://www.epa.gov/
dockets.
II. Summary of Petitioned-For
Exemption
In the Federal Register of March 14,
2012 (77 FR 15012) (FRL–9335–9), EPA
issued a document pursuant to FFDCA
section 408(d)(3), 21 U.S.C. 346a(d)(3),
announcing the filing of a pesticide
tolerance petition (PP 1F7914) by
Albemarle Corporation, 451 Florida
Street, Baton Rouge, LA 70801. The
petition requested that 40 CFR
180.940(a) be amended by establishing
an exemption from the requirement of a
tolerance for residues of the
antimicrobial 1,3-dibromo-5,5dimethylhydantoin resulting from the
use of this antimicrobial in food contact
surface sanitizing solutions applied to
food contact surfaces in public eating
places, dairy processing equipment, and
food-processing equipment and utensils
at concentrations not to exceed 500
parts per million (ppm) of total bromine.
The petition also requested
establishment of an exemption from the
requirement of a tolerance for residues
of the antimicrobial 1,3-dibromo-5,5dimethylhydantoin in or on all raw
agricultural commodities resulting from
the use of 1,3-dibromo-5,5dimethylhydantoin as an antimicrobial
treatment in solutions containing a
diluted end-use concentration of all
bromide-producing chemicals in the
solution not to exceed 900 ppm of total
bromine. That document referenced a
summary of the petition prepared by
Albemarle Corporation, the petitioner,
which is available in the docket, https://
www.regulations.gov. There were no
comments received in response to the
notice of filing.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(c)(2)(A)(i) of FFDCA
allows EPA to establish an exemption
VerDate Sep<11>2014
17:53 Dec 04, 2017
Jkt 244001
from the requirement for a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the exemption is ‘‘safe.’’
Section 408(c)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Pursuant to
FFDCA section 408(c)(2)(B), in
establishing or maintaining in effect an
exemption from the requirement of a
tolerance, EPA must take into account
the factors set forth in FFDCA section
408(b)(2)(C), which requires EPA to give
special consideration to exposure of
infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue . . . .’’
Consistent with FFDCA section
408(c)(2)(A), and the factors specified in
FFDCA section 408(c)(2)(B), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for 1,3-dibromo-5,5dimethylhydantoin including exposure
resulting from the exemption
established by this action. EPA’s
assessment of exposures and risks
associated with 1,3-dibromo-5,5dimethylhydantoin follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
Exposures to 1,3-dibromo-5,5dimethylhydantoin (DBDMH) only
occur during the mixing of the treatment
solution. These exposures would only
be associated with the occupational
handling/applying when pouring and
mixing with water. When mixed with
water, DBDMH rapidly hydrolyzes to
5,5-dimethylhydantion (DMH). DMH is
stable in water and is the residue
available for dietary exposure.
Most of the toxicology studies
submitted to the Agency in support of
PO 00000
Frm 00038
Fmt 4700
Sfmt 4700
registration of DBDMH were conducted
on DMH (including subchronic oral
toxicity in the rat and dog; subchronic
dermal toxicity in the rat; chronic
toxicity in the dog; combined chronic/
oncogenicity in the rat and mouse;
oncogenicity in the mouse;
developmental toxicity in the rat and
rabbit; 2-generation reproductive
toxicity in the rat; genotoxicity battery;
and general metabolism in the rat).
These studies generally show lack of
systemic toxicity up to the limit dose.
No specific target organs were identified
in adult animals tested. No
developmental or maternal toxicity was
observed. There was no evidence of
carcinogenicity. There is also no
indication of neurotoxicity or
immunotoxicity in the database.
The formation of the bromide ion is
also present during the degradation of
DBDMH. Based on available data, the
Agency has previously determined that
bromine does not present adverse
systemic effects and therefore no
endpoints were identified. See Bromine
Final Registration Review Decision, Case
4015, which is document number 10 in
docket number EPA–HQ–OPP–2009–
0167, in www.regulations.gov. Based on
its previous assessment, which remains
valid, the Agency has determined that
there are no risks of concern from
exposures to bromine.
Specific information on the studies
received from the toxicity studies can be
found at https://www.regulations.gov in
document 1,3-dibromo-5,5dimethylhydantoin (DBDMH), Human
health and ecological risk assessment
for the new use as a Fruit and Vegetable
Wash and Food Contact Surface
Sanitizer in docket ID number EPA–
HQ–OPP–2011–1033.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
E:\FR\FM\05DER1.SGM
05DER1
Federal Register / Vol. 82, No. 232 / Tuesday, December 5, 2017 / Rules and Regulations
sradovich on DSK3GMQ082PROD with RULES
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect in
a lifetime. For more information on the
general principles EPA uses in risk
characterization and a complete
description of the risk assessment
process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
The Agency did not identify any
toxicological points of departure
because the available data indicate a
lack of toxicity for DBDMH and its
degradates (DMH and the bromide ion).
C. Exposure Assessment
1. Dietary exposure from food uses
and drinking water. Based on the use
patterns for DBDMH, residues of the
degradate DMH may be present in or on
food as a result of exposure to the
substance in treatment solutions or on
treated food contact surfaces. DMH
residues are unlikely to be in drinking
water because the product is intended to
be used in treatment solutions in RAC
treatment facilities and on food contact
surfaces in public eating places or
processing. Nevertheless, because of the
lack of toxicological endpoints,
quantitative dietary food and drinking
water exposure and risk assessments
were not conducted.
2. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., textiles (clothing and diapers),
carpets, swimming pools, and hard
surface disinfection on walls, floors,
tables). 1,3-dibromo-5,5dimethylhydantoin is not registered for
use on any sites that would result in
residential exposure. Further
information regarding EPA standard
assumptions and generic inputs for
residential exposures may be found at
https://www.epa.gov/pesticides/trac/
science/trac6a05.pdf.
3. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found 1,3-dibromo-5,5dimethylhydantoin to share a common
mechanism of toxicity with any other
substances, and 1,3-dibromo-5,5dimethylhydantoin does not appear to
VerDate Sep<11>2014
17:53 Dec 04, 2017
Jkt 244001
produce a toxic metabolite produced by
other substances. Based on the lack of
toxicity for DBDMH and its metabolites
and degradates, therefore, EPA
concludes that 1,3-dibromo-5,5dimethylhydantoin does not have a
common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such chemical,
see EPA’s Web site at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and
Children
Section 408(b)(2)(C) of FFDCA
provides that EPA shall apply an
additional tenfold (10X) margin of safety
for infants and children in the case of
threshold effects to account for prenatal
and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
Food Quality Protection Act (FQPA)
Safety Factor (SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
There are adequate pre- and/or postnatal toxicity studies for DMH that show
no qualitative or quantitative
susceptibility from exposure to DMH.
As a result, the Agency has conducted
a qualitative assessment in which safety
factors were not relevant. Moreover,
because of the lack of any threshold
effects, the requirement to retain an
additional 10X safety factor does not
apply.
E. Aggregate Risks and Determination of
Safety
Based on the toxicological profile of
DBDMH, EPA concludes that exposures
to the antimicrobial 1,3-dibromo-5,5dimethylhydantoin will not pose a risk
under reasonably foreseeable
circumstances. In order to use this
substance as antimicrobial treatment in
process water and as a food contact
surface sanitizer, the substance must be
mixed with water, necessarily resulting
in the conversion of DMDBH into DMH
and bromine, for which the Agency has
not identified any toxicological
endpoints of concern. Therefore, the
Agency concludes that reasonably
foreseeable uses of this substance are
safe. Accordingly, EPA finds that there
is a reasonable certainty of no harm will
result to the general population, or to
PO 00000
Frm 00039
Fmt 4700
Sfmt 4700
57369
infants and children from aggregate
exposure to 1,3-dibromo-5,5dimethylhydantoin residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
An analytical method is not required
for enforcement purposes since the
Agency is establishing an exemption
from the requirement of a tolerance
without any numerical limitation.
B. Revisions to Petitioned-For
Exemption
Although the petitioner requested
exemptions for residues of 1,3-dibromo5,5-dimethylhydantoin with limitations
on the amount of DBDMH in sanitizing
and antimicrobial treatment solutions,
EPA is establishing exemptions, without
the requested limitations, for residues of
1,3-dibromo-5,5-dimethylhydantoin,
because of the lack of toxicity of
DMDBH and its metabolites and
degradates.
V. Conclusion
Therefore, exemptions from the
requirement of a tolerance are
established for residues of 1,3-dibromo5,5-dimethylhydantoin as follows:
When used in food contact surface
sanitizing solutions applied to food
contact surfaces in public eating places,
dairy-processing equipment, and foodprocessing equipment and utensils and
when used as an antimicrobial
treatment in solutions applied to raw
agricultural commodities in treatment
facilities.
VI. Statutory and Executive Order
Reviews
This action establishes exemptions
from tolerance under FFDCA section
408(d) in response to a petition
submitted to the Agency. The Office of
Management and Budget (OMB) has
exempted these types of actions from
review under Executive Order 12866,
entitled ‘‘Regulatory Planning and
Review’’ (58 FR 51735, October 4, 1993).
Because this action has been exempted
from review under Executive Order
12866, this action is not subject to
Executive Order 13211, entitled
‘‘Actions Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use’’ (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled ‘‘Protection of Children from
Environmental Health Risks and Safety
Risks’’ (62 FR 19885, April 23, 1997).
This action does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et
seq.), nor does it require any special
considerations under Executive Order
E:\FR\FM\05DER1.SGM
05DER1
57370
Federal Register / Vol. 82, No. 232 / Tuesday, December 5, 2017 / Rules and Regulations
12898, entitled ‘‘Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
Dated: November 15, 2017.
Steven Weiss,
Acting Director, Antimicrobials Division,
Office of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.940, add alphabetically the
pesticide chemical ‘‘1,3-dibromo-5,5dimethylhydantoin’’ to the table in
paragraph (a) to read as follows:
■
§ 180.940 Tolerance exemptions for active
and inert ingredients for use in
antimicrobial formulations (Food-contact
surface sanitizing solutions).
*
*
*
(a) * * *
*
*
Pesticide chemical
CAS
Reg. No.
*
*
*
1,3-dibromo-5,5dimethylhydantoin.
*
77–48–5
*
*
*
Limits
*
None.
*
*
3. Add § 180.1346 to subpart D to read
as follows:
■
§ 180.1346 1,3-Dibromo-5,5Dimethylhydantoin; exemption from the
requirement of a tolerance.
Residues of 1,3-dibromo-5,5dimethylhydantoin, including its
metabolites and degradates, resulting
from the use of 1,3-dibromo-5,5dimethylhydantoin in antimicrobial
treatment solutions of raw agricultural
commodities in treatment facilities are
exempt from the requirement of a
tolerance.
[FR Doc. 2017–25842 Filed 12–4–17; 8:45 am]
sradovich on DSK3GMQ082PROD with RULES
BILLING CODE 6560–50–P
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
VerDate Sep<11>2014
17:53 Dec 04, 2017
Jkt 244001
SURFACE TRANSPORTATION BOARD
49 Parts 1104, 1109, 1111, 1114, and
1130
[Docket No. EP 733]
Expediting Rate Cases
Surface Transportation Board.
Final rule.
AGENCY:
ACTION:
Pursuant to section 11 of the
Surface Transportation Board
Reauthorization Act of 2015 (STB
Reauthorization Act), the Surface
Transportation Board (Board) is
SUMMARY:
PO 00000
Frm 00040
Fmt 4700
Sfmt 4700
modifying rules pertaining to its rate
case procedures.
DATES: This rule is effective on
December 30, 2017.
ADDRESSES: Requests for information or
questions regarding this final rule
should reference Docket No. EP 733 and
be in writing addressed to: Chief,
Section of Administration, Office of
Proceedings, Surface Transportation
Board, 395 E Street SW., Washington,
DC 20423–0001.
FOR FURTHER INFORMATION CONTACT:
Valerie Quinn, (202) 245–0283.
Assistance for the hearing impaired is
available through the Federal
Information Relay Service (FIRS) at
(800) 877–8339.
SUPPLEMENTARY INFORMATION: Section 11
of the STB Reauthorization Act, Public
Law 114–110, 129 Stat. 2228 (2015),
directs the Board to ‘‘initiate a
proceeding to assess procedures that are
available to parties in litigation before
courts to expedite such litigation and
the potential application of any such
procedures to rate cases.’’ In addition,
section 11 requires the Board to comply
with a new timeline in Stand-Alone
Cost (SAC) cases.
In advance of initiating this
proceeding, Board staff held informal
meetings with stakeholders 1 to explore
and discuss: (1) How procedures to
expedite court litigation could be
applied to rate cases and (2) additional
ways to move SAC cases forward more
expeditiously. The Board issued an
Advance Notice of Proposed
Rulemaking on June 15, 2016, seeking
formal comment on specific ideas raised
in the informal meetings as well as
comments on any other relevant
matters. Expediting Rate Cases
(ANPRM), EP 733 (STB served June 15,
2016). See 81 FR 40250 (June 21, 2016).
The Board received eight opening
comments and six reply comments on
the ANPRM.
On March 31, 2017, the Board issued
a Notice of Proposed Rulemaking,
addressing the comments on the
ANPRM and proposing specific
1 Board staff met with individuals either
associated with and/or speaking on behalf of the
following organizations: American Chemistry
Council; Archer Daniels Midland Company; CSX
Transportation, Inc.; Economists Incorporated; Dr.
Gerald Faulhaber; FTI Consulting, Inc.; GKG Law,
P.C.; Growth Energy; Highroad Consulting; L.E.
Peabody; LaRoe, Winn, Moerman & Donovan;
consultant Michael A. Nelson; Norfolk Southern
Railway Company (NSR); Olin Corporation; POET
Ethanol Products; Sidley Austin LLP; Slover &
Loftus LLP; Steptoe & Johnson LLP; The Chlorine
Institute; The Fertilizer Institute; The National
Industrial Transportation League; and Thompson
Hine LLP. The Board notes that some participants
expressed individual views, not on behalf of the
organization(s) with which they are associated.
E:\FR\FM\05DER1.SGM
05DER1
Agencies
[Federal Register Volume 82, Number 232 (Tuesday, December 5, 2017)]
[Rules and Regulations]
[Pages 57367-57370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25842]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2011-1033; FRL-9968-30]
1,3-dibromo-5,5-dimethylhydantoin; Exemption From the Requirement
of a Tolerance
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of 1,3-dibromo-5,5-dimethylhydantoin in or
on food when used in antimicrobial pesticide formulations applied to
food contact surfaces in public eating places, dairy processing
equipment, and/or food processing equipment and utensils. In addition,
this regulation establishes an exemption from the requirement of a
tolerance for residues of 1,3-dibromo-5,5-dimethylhydantoin when used
as an antimicrobial pesticide treatment solution. Albemarle Corporation
submitted a petition to EPA under the Federal Food, Drug, and Cosmetic
Act (FFDCA), requesting exemptions from the requirement of a tolerance
for residues of 1,3-dibromo-5,5-dimethylhydantoin in end-use products
applied to food contact surfaces and used for washing raw agricultural
commodities. This regulation eliminates the need to establish a maximum
permissible level of residues of 1,3-dibromo-5,5-dimethylhydantoin
resulting from uses consistent with the terms of these exemptions.
DATES: This regulation is effective December 5, 2017. Objections and
requests for hearings must be received on or before February 5, 2018,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2011-1033, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Steven H. Weiss, Antimicrobials
Division (7510P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001; main telephone number: (703) 308-6411; email address:
ADFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111), e.g., agricultural
workers; greenhouse, nursery, and floriculture workers; farmers.
Animal production (NAICS code 112), e.g., cattle ranchers
and farmers, dairy cattle farmers, livestock farmers.
Food manufacturing (NAICS code 311), e.g., agricultural
workers; farmers; greenhouse, nursery, and floriculture workers;
ranchers; pesticide applicators.
Pesticide manufacturing (NAICS code 32532), e.g.,
agricultural workers; commercial applicators; farmers; greenhouse,
nursery, and floriculture workers; residential users.
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of 40 CFR
part 180 through the Government Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl. To access the OSCPP test guidelines referenced in this
document electronically, please go to https://www.epa.gov/ocspp and
select ``Test Methods and Guidelines.''
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2011-1033 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
February 5, 2018. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2011-1033, by one of
the following methods:
[[Page 57368]]
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Exemption
In the Federal Register of March 14, 2012 (77 FR 15012) (FRL-9335-
9), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide tolerance
petition (PP 1F7914) by Albemarle Corporation, 451 Florida Street,
Baton Rouge, LA 70801. The petition requested that 40 CFR 180.940(a) be
amended by establishing an exemption from the requirement of a
tolerance for residues of the antimicrobial 1,3-dibromo-5,5-
dimethylhydantoin resulting from the use of this antimicrobial in food
contact surface sanitizing solutions applied to food contact surfaces
in public eating places, dairy processing equipment, and food-
processing equipment and utensils at concentrations not to exceed 500
parts per million (ppm) of total bromine. The petition also requested
establishment of an exemption from the requirement of a tolerance for
residues of the antimicrobial 1,3-dibromo-5,5-dimethylhydantoin in or
on all raw agricultural commodities resulting from the use of 1,3-
dibromo-5,5-dimethylhydantoin as an antimicrobial treatment in
solutions containing a diluted end-use concentration of all bromide-
producing chemicals in the solution not to exceed 900 ppm of total
bromine. That document referenced a summary of the petition prepared by
Albemarle Corporation, the petitioner, which is available in the
docket, https://www.regulations.gov. There were no comments received in
response to the notice of filing.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the exemption is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and in residential settings, but does not include
occupational exposure. Pursuant to FFDCA section 408(c)(2)(B), in
establishing or maintaining in effect an exemption from the requirement
of a tolerance, EPA must take into account the factors set forth in
FFDCA section 408(b)(2)(C), which requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue . .
. .''
Consistent with FFDCA section 408(c)(2)(A), and the factors
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for 1,3-dibromo-5,5-
dimethylhydantoin including exposure resulting from the exemption
established by this action. EPA's assessment of exposures and risks
associated with 1,3-dibromo-5,5-dimethylhydantoin follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
Exposures to 1,3-dibromo-5,5-dimethylhydantoin (DBDMH) only occur
during the mixing of the treatment solution. These exposures would only
be associated with the occupational handling/applying when pouring and
mixing with water. When mixed with water, DBDMH rapidly hydrolyzes to
5,5-dimethylhydantion (DMH). DMH is stable in water and is the residue
available for dietary exposure.
Most of the toxicology studies submitted to the Agency in support
of registration of DBDMH were conducted on DMH (including subchronic
oral toxicity in the rat and dog; subchronic dermal toxicity in the
rat; chronic toxicity in the dog; combined chronic/oncogenicity in the
rat and mouse; oncogenicity in the mouse; developmental toxicity in the
rat and rabbit; 2-generation reproductive toxicity in the rat;
genotoxicity battery; and general metabolism in the rat). These studies
generally show lack of systemic toxicity up to the limit dose. No
specific target organs were identified in adult animals tested. No
developmental or maternal toxicity was observed. There was no evidence
of carcinogenicity. There is also no indication of neurotoxicity or
immunotoxicity in the database.
The formation of the bromide ion is also present during the
degradation of DBDMH. Based on available data, the Agency has
previously determined that bromine does not present adverse systemic
effects and therefore no endpoints were identified. See Bromine Final
Registration Review Decision, Case 4015, which is document number 10 in
docket number EPA-HQ-OPP-2009-0167, in www.regulations.gov. Based on
its previous assessment, which remains valid, the Agency has determined
that there are no risks of concern from exposures to bromine.
Specific information on the studies received from the toxicity
studies can be found at https://www.regulations.gov in document 1,3-
dibromo-5,5-dimethylhydantoin (DBDMH), Human health and ecological risk
assessment for the new use as a Fruit and Vegetable Wash and Food
Contact Surface Sanitizer in docket ID number EPA-HQ-OPP-2011-1033.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a
[[Page 57369]]
reference dose (RfD)--and a safe margin of exposure (MOE). For non-
threshold risks, the Agency assumes that any amount of exposure will
lead to some degree of risk. Thus, the Agency estimates risk in terms
of the probability of an occurrence of the adverse effect in a
lifetime. For more information on the general principles EPA uses in
risk characterization and a complete description of the risk assessment
process, see https://www.epa.gov/pesticides/factsheets/riskassess.htm.
The Agency did not identify any toxicological points of departure
because the available data indicate a lack of toxicity for DBDMH and
its degradates (DMH and the bromide ion).
C. Exposure Assessment
1. Dietary exposure from food uses and drinking water. Based on the
use patterns for DBDMH, residues of the degradate DMH may be present in
or on food as a result of exposure to the substance in treatment
solutions or on treated food contact surfaces. DMH residues are
unlikely to be in drinking water because the product is intended to be
used in treatment solutions in RAC treatment facilities and on food
contact surfaces in public eating places or processing. Nevertheless,
because of the lack of toxicological endpoints, quantitative dietary
food and drinking water exposure and risk assessments were not
conducted.
2. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., textiles (clothing and diapers), carpets, swimming
pools, and hard surface disinfection on walls, floors, tables). 1,3-
dibromo-5,5-dimethylhydantoin is not registered for use on any sites
that would result in residential exposure. Further information
regarding EPA standard assumptions and generic inputs for residential
exposures may be found at https://www.epa.gov/pesticides/trac/science/trac6a05.pdf.
3. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found 1,3-dibromo-5,5-dimethylhydantoin to share a
common mechanism of toxicity with any other substances, and 1,3-
dibromo-5,5-dimethylhydantoin does not appear to produce a toxic
metabolite produced by other substances. Based on the lack of toxicity
for DBDMH and its metabolites and degradates, therefore, EPA concludes
that 1,3-dibromo-5,5-dimethylhydantoin does not have a common mechanism
of toxicity with other substances. For information regarding EPA's
efforts to determine which chemicals have a common mechanism of
toxicity and to evaluate the cumulative effects of such chemical, see
EPA's Web site at https://www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an
additional tenfold (10X) margin of safety for infants and children in
the case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the database on toxicity and exposure
unless EPA determines based on reliable data that a different margin of
safety will be safe for infants and children. This additional margin of
safety is commonly referred to as the Food Quality Protection Act
(FQPA) Safety Factor (SF). In applying this provision, EPA either
retains the default value of 10X, or uses a different additional safety
factor when reliable data available to EPA support the choice of a
different factor.
There are adequate pre- and/or post-natal toxicity studies for DMH
that show no qualitative or quantitative susceptibility from exposure
to DMH. As a result, the Agency has conducted a qualitative assessment
in which safety factors were not relevant. Moreover, because of the
lack of any threshold effects, the requirement to retain an additional
10X safety factor does not apply.
E. Aggregate Risks and Determination of Safety
Based on the toxicological profile of DBDMH, EPA concludes that
exposures to the antimicrobial 1,3-dibromo-5,5-dimethylhydantoin will
not pose a risk under reasonably foreseeable circumstances. In order to
use this substance as antimicrobial treatment in process water and as a
food contact surface sanitizer, the substance must be mixed with water,
necessarily resulting in the conversion of DMDBH into DMH and bromine,
for which the Agency has not identified any toxicological endpoints of
concern. Therefore, the Agency concludes that reasonably foreseeable
uses of this substance are safe. Accordingly, EPA finds that there is a
reasonable certainty of no harm will result to the general population,
or to infants and children from aggregate exposure to 1,3-dibromo-5,5-
dimethylhydantoin residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption from the requirement of a
tolerance without any numerical limitation.
B. Revisions to Petitioned-For Exemption
Although the petitioner requested exemptions for residues of 1,3-
dibromo-5,5-dimethylhydantoin with limitations on the amount of DBDMH
in sanitizing and antimicrobial treatment solutions, EPA is
establishing exemptions, without the requested limitations, for
residues of 1,3-dibromo-5,5-dimethylhydantoin, because of the lack of
toxicity of DMDBH and its metabolites and degradates.
V. Conclusion
Therefore, exemptions from the requirement of a tolerance are
established for residues of 1,3-dibromo-5,5-dimethylhydantoin as
follows: When used in food contact surface sanitizing solutions applied
to food contact surfaces in public eating places, dairy-processing
equipment, and food-processing equipment and utensils and when used as
an antimicrobial treatment in solutions applied to raw agricultural
commodities in treatment facilities.
VI. Statutory and Executive Order Reviews
This action establishes exemptions from tolerance under FFDCA
section 408(d) in response to a petition submitted to the Agency. The
Office of Management and Budget (OMB) has exempted these types of
actions from review under Executive Order 12866, entitled ``Regulatory
Planning and Review'' (58 FR 51735, October 4, 1993). Because this
action has been exempted from review under Executive Order 12866, this
action is not subject to Executive Order 13211, entitled ``Actions
Concerning Regulations That Significantly Affect Energy Supply,
Distribution, or Use'' (66 FR 28355, May 22, 2001) or Executive Order
13045, entitled ``Protection of Children from Environmental Health
Risks and Safety Risks'' (62 FR 19885, April 23, 1997). This action
does not contain any information collections subject to OMB approval
under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor
does it require any special considerations under Executive Order
[[Page 57370]]
12898, entitled ``Federal Actions to Address Environmental Justice in
Minority Populations and Low-Income Populations'' (59 FR 7629, February
16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: November 15, 2017.
Steven Weiss,
Acting Director, Antimicrobials Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.940, add alphabetically the pesticide chemical ``1,3-
dibromo-5,5-dimethylhydantoin'' to the table in paragraph (a) to read
as follows:
Sec. 180.940 Tolerance exemptions for active and inert ingredients
for use in antimicrobial formulations (Food-contact surface sanitizing
solutions).
* * * * *
(a) * * *
------------------------------------------------------------------------
CAS Reg.
Pesticide chemical No. Limits
------------------------------------------------------------------------
* * * * *
1,3-dibromo-5,5-dimethylhydantoin..... 77-48-5 None.
* * * * *
------------------------------------------------------------------------
0
3. Add Sec. 180.1346 to subpart D to read as follows:
Sec. 180.1346 1,3-Dibromo-5,5-Dimethylhydantoin; exemption from the
requirement of a tolerance.
Residues of 1,3-dibromo-5,5-dimethylhydantoin, including its
metabolites and degradates, resulting from the use of 1,3-dibromo-5,5-
dimethylhydantoin in antimicrobial treatment solutions of raw
agricultural commodities in treatment facilities are exempt from the
requirement of a tolerance.
[FR Doc. 2017-25842 Filed 12-4-17; 8:45 am]
BILLING CODE 6560-50-P